icose
veins: a randomized clinical trial. J Vasc Surg Venous Lymphat
Disord 2020;8:211-5.
183. Bademci MS, Kocaaslan C, Aldag M, Yalvac ESD, Oztekin A, Bulut N, et al.
Single-center retrospective review of early outcomes of radiofrequency
ablation versus cyanoacrylate ablation of isolated great saphenous vein
insufﬁciency. J Vasc Surg Venous Lymphat Disord 2019;7:480-5.
 lan O. A comparison of NBCA and RFA in treating varicose
184. Bozog
veins in the same patient. E J Cardiovasc Med 2020;8:45-50.
185. Gonzalez-Zeh R, Armisen R, Barahona S. Endovenous laser and
echo-guided foam ablation in great saphenous vein reﬂux: one-year
follow-up results. J Vasc Surg 2008;48:940-6.
186. Koramaz I, El Kilic H, Gokalp F, Bitargil M, Bektas N, Engin E, et al.
Ablation of the great saphenous vein with nontumescent n-butyl
cyanoacrylate versus endovenous laser therapy. J Vasc Surg Venous
Lymphat Disord 2017;5:210-5.
187. McGuinness B, Elias F, Ali KP, Ahmad MS, Namburi J, Chan B, et al.
A comparison of duplex ultrasound ﬁndings after cyanoacrylate
embolization versus endovenous laser ablation of the great
saphenous vein. J Vasc Surg Venous Lymphat Disord 2019;7:824-31.
188. Ovali C, Sevin MB. Twelve-month efﬁcacy and complications of
cyanoacrylate embolization compared with radiofrequency ablation for incompetent great saphenous veins. J Vasc Surg Venous
Lymphat Disord 20